TG Therapeutics Secures $500M to Advance BRIUMVI in Relapsing Multiple Sclerosis
Biotech
Novartis Expands US Radioligand Manufacturing With $23 Billion Investment in Florida
Pharma
Novartis Invests $23 Billion to Boost Radioligand Manufacturing Capacity in Carlsbad
AstraZeneca makes deal with Trump Admin to Cut Drug Prices 80% and Invest $50B in US
In Vivo CAR T on the Horizon: BMS Acquires Orbital to Expand Cell Therapy Reach
GSK to invest $30 billion in R&D and Manufacturing in the US over next 5 years
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
FDA & EMA
AI-Driven bioX Genetics Platform Slashes Genetic Variant Detection Time
Vividion and Bayer Advance First-in-Class WRN Inhibitor VVD-214 for Solid Tumors
BioNTech and BMS Forge Partnership to Advance BNT327 for Solid Tumors
Merck Expands US Bio Manufacturing with $1B Wilmington Facility for KEYTRUDA
Boehringer and Tessellate Partner to Develop Treatments for Hard-to-Treat Cancers
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
AbbVie Acquires Nimble in $200 Million Deal to Strengthen Immunology Pipeline
General Inception Acquires Enable Medicine to Drive AI-Led Drug Discovery
Elevation Partners with Synaffix in $368M Deal to Advance HER3 ADC Development
Roche Acquires Poseida in $1.5 Billion Deal to Advance Cell Therapy Innovation
Sanofi and Orano Join Forces to Develop Novel Radioligand Therapies for Rare Cancers
The Role of Pharmacists in the Fight Against Liver Disease / Interview with Dr. Duggan
Flindr Receives €20 Million to Advance Precision Cancer Treatments with RNF31 Inhibitor
AstraZeneca's $2.4 Billion Strategic Move: Acquiring Fusion for Radiopharmaceutical
Gilead and Merus Forge $1.5 Billion Oncology Alliance to Novel Cancer Treatments
The Global CAR T-Cell Therapy Market's Ascent: From $8.2 B in 2022 to $11.2 B by 2030
J&J's $2 Billion Strategic Acquisition of Ambrx Biopharma: Leading in ADC Oncology
Scemblix Outperforms Standard TKIs in Phase III Chronic Myeloid Leukemia Trial
Merck's $680 Million Strategic Move to Boost Oncology Pipeline with Harpoon Acquisition
Novartis Launches Its Largest RLT Facility in Indianapolis, Enhancing Pluvicto Production
AbbVie and Umoja Collaborate to Advance CAR-T Cell Therapy
Novo Nordisk, Omega and Cellarity Collaborate to Reshape Future of Obesity and MASH
Boehringer Ingelheim and 3T Forge Alliance to Advance Cancer Immunotherapies
Subscribe for the latest news and events
Most Popular
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
